Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page
- Factor B, in C2-deficient SLE, 427
- Familial Mediterranean fever, diagnostic criteria, 1516, 1517
- Fas/Fas ligand (FasL)
- anti-tumor necrosis factor effects on, 139
- in Kawasaki disease, 568
- in murine cytomegalovirus SS-like disease, 2175
- in OA, 657
- in RA, 657
- in SLE, 344, 596, 823, 1251
- Fatigue
- in RA, long-term risk for pain, depression, disability, and, 1851
- in RA, predictors of subjective, 2230
- Fcγ receptor type IIa polymorphisms in SLE, 421, 1181
- FcγRIIa-158V/F polymorphisms, in SLE, 1813
- Fibrillin 1 (FBN1), and SSc in Choctaw, 1729
- Fibroblastic rheumatism
- destructive arthropathy in, 379
- fifteen-year followup study of, 759
- Fibroblasts
- collagenase 1 inhibition by interleukin-4 in synovial, 1398
- matrix metalloproteinase 1 and tissue inhibitor of metalloproteinases in, 1748
- nuclear factor [gk]B/p50 activation of distal metalloproteinase-1 promoter in synovial, 1987
- procollagen gene expression in tight skin 2 mice, 2132
- Fibromyalgia
- versus altered nociception, after spinal injury, 183
- collagen crosslinks in, 948
- dysautonomia in, 1966
- neuropeptides in muscle tissue in, 1689
- P-31 MRS in, 406
- prevalence in United States, 778
- relation to site and type of trauma, 378
- Fingers
- knuckle cracking and arthritis of, 949
- osseous sarcoidosis of, 176
- Fractures
- compression, percutaneous vertebroplasty treatment of, 171
- rheumatoid burst, 747
